1.85
price down icon0.54%   -0.01
pre-market  Pre-market:  1.84   -0.01   -0.54%
loading
Hillevax Inc stock is traded at $1.85, with a volume of 179.85K. It is down -0.54% in the last 24 hours and up +10.12% over the past month. HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$1.86
Open:
$1.84
24h Volume:
179.85K
Relative Volume:
0.93
Market Cap:
$84.74M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.6086
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
+9.47%
1M Performance:
+10.12%
6M Performance:
+1.65%
1Y Performance:
-85.29%
1-Day Range:
Value
$1.80
$1.86
1-Week Range:
Value
$1.65
$1.86
52-Week Range:
Value
$1.34
$16.30

Hillevax Inc Stock (HLVX) Company Profile

Name
Name
Hillevax Inc
Name
Phone
(617) 213-5054
Name
Address
321 HARRISON AVE, SUITE 500, BOSTON
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2025-03-28
Name
Latest SEC Filings
Name
HLVX's Discussions on Twitter

Compare HLVX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HLVX
Hillevax Inc
1.85 84.74M 0 -123.57M -97.53M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.47 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
599.76 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
600.51 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.61 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.16 24.89B 3.81B -644.79M -669.77M -6.24

Hillevax Inc Stock (HLVX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-09-24 Downgrade H.C. Wainwright Buy → Neutral
Jul-09-24 Downgrade Leerink Partners Outperform → Market Perform
Jul-09-24 Downgrade Stifel Buy → Hold
Jul-08-24 Downgrade Guggenheim Buy → Neutral
Jul-08-24 Downgrade JP Morgan Overweight → Neutral
Dec-13-23 Initiated H.C. Wainwright Buy
View All

Hillevax Inc Stock (HLVX) Latest News

pulisher
01:18 AM

Press Release Distribution & PR Platform - ACCESS Newswire

01:18 AM
pulisher
Apr 23, 2025

Is HilleVax Inc (HLVX) worth investing in despite its overvalued state? - uspostnews.com

Apr 23, 2025
pulisher
Apr 08, 2025

ATTENTION HLVX SHAREHOLDERS: Investors who Lost Money on HilleVax, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 03, 2025

HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 03, 2025

HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Consensus Price Target from Brokerages - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks

Mar 31, 2025
pulisher
Mar 30, 2025

HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN

Mar 30, 2025
pulisher
Mar 28, 2025

HilleVax Inc. (HLVX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

HilleVax, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times

Mar 28, 2025
pulisher
Mar 25, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 13, 2025

HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 12, 2025
pulisher
Mar 10, 2025

HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World

Mar 10, 2025
pulisher
Feb 27, 2025

HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 17, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria

Feb 17, 2025
pulisher
Feb 17, 2025

Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News

Feb 17, 2025
pulisher
Feb 15, 2025

Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World

Feb 15, 2025
pulisher
Feb 13, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Top Executives Cash In on HilleVax Stock Sales - TipRanks

Feb 12, 2025
pulisher
Feb 12, 2025

HilleVax Executives Sell Shares in February 2025 - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World

Feb 12, 2025
pulisher
Jan 27, 2025

HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 25, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World

Jan 25, 2025
pulisher
Jan 14, 2025

Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 14, 2025
pulisher
Jan 10, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 10, 2025
pulisher
Jan 07, 2025

Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World

Jan 07, 2025
pulisher
Jan 03, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by State Street Corp - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Cancer Vaccine Breaking News - Vax-Before-Travel

Jan 02, 2025
pulisher
Jan 01, 2025

Short Interest in HilleVax, Inc. (NASDAQ:HLVX) Expands By 7.4% - MarketBeat

Jan 01, 2025
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 19, 2024
pulisher
Dec 15, 2024

Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 15, 2024
pulisher
Dec 10, 2024

HilleVax, Inc. Announces Management Changes - Marketscreener.com

Dec 10, 2024
pulisher
Dec 09, 2024

3 US Penny Stocks With Market Caps Under $100M - simplywall.st

Dec 09, 2024
pulisher
Dec 06, 2024

HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia

Dec 06, 2024
pulisher
Dec 05, 2024

HilleVax initiates major workforce reduction, executives depart - Investing.com

Dec 05, 2024
pulisher
Dec 05, 2024

HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch

Dec 05, 2024
pulisher
Dec 05, 2024

HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks

Dec 05, 2024
pulisher
Dec 05, 2024

Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World

Dec 05, 2024

Hillevax Inc Stock (HLVX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Hillevax Inc Stock (HLVX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
HERSHBERG ROBERT
See Remarks
Feb 11 '25
Sale
1.76
11,901
21,003
1,101,498
Maltbie Shane
Chief Financial Officer
Feb 11 '25
Sale
1.76
4,345
7,659
79,887
Maltbie Shane
Chief Financial Officer
Feb 04 '25
Sale
1.89
3,946
7,458
84,232
Kohli Aditya
Director
May 20 '24
Sale
15.45
6,000
92,689
776,878
Kohli Aditya
Director
May 22 '24
Sale
14.73
6,000
88,372
764,878
Kohli Aditya
Director
May 21 '24
Sale
14.21
6,000
85,230
770,878
Kohli Aditya
Director
May 02 '24
Sale
14.01
6,000
84,081
783,601
Kohli Aditya
Director
May 03 '24
Sale
14.15
723
10,233
782,878
Kohli Aditya
Director
May 01 '24
Sale
14.03
175
2,456
789,601
$20.54
price up icon 2.04%
$68.96
price down icon 2.60%
$32.03
price up icon 1.07%
$36.70
price up icon 10.44%
$120.54
price up icon 4.97%
biotechnology ONC
$256.16
price up icon 2.82%
Cap:     |  Volume (24h):